| 标题 |
Re: Darolutamide plus Androgen-deprivation Therapy and Docetaxel in Metastatic Hormone-sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | Ghamande SS, Klaassen Z, Wallis CJD. Re: Darolutamide plus Androgen-deprivation Therapy and Docetaxel in Metastatic Hormone-sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial. Eur Urol. 2023 Sep;84(3):350-351. doi: 10.1016/j.eururo.2023.04.031. Epub 2023 May 12. PMID: 37183160. |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)